Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$25.4M-15.8%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$395.96M-22.1%
Regenxbio logo
RegenxbioRGNX
$341.89M-30.4%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s total assets?
Immix Biopharma, Inc. (IMMX) reported total assets of $95.82M in Q1 2026.
How has Immix Biopharma, Inc.'s total assets changed year-over-year?
Immix Biopharma, Inc.'s total assets increased by 381.7% year-over-year, from $19.89M to $95.82M.
What is the long-term trend for Immix Biopharma, Inc.'s total assets?
Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s total assets has grown at a 186.9% compound annual growth rate (CAGR), from $539.6K to $104.84M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.